LONDON–(BUSINESS WIRE)–#GMP–The global anti-malarial medicines market 2018-2022 is expected to post
a CAGR of close to 5% during the forecast period, according to the
latest market research report by Technavio.
A key factor driving the growth of the market is a strong funding to
eradicate malaria. The funding for malaria
is increasing day by day as it is on the eradication list of the WHO.
Various government and non-government organizations, such as MMV, Bill &
Melinda Gates Foundation, and The World Bank, are conducting various
awareness camps, which are supported by strong funding. The WHO Global
Malaria Program (GMP) is coordinating the WHO’s global effort to control
and eliminate malaria.
This market research report on the global
anti-malarial medicines market 2018-2022 also provides an
analysis of the most important trends expected to impact the market
outlook during the forecast period. Technavio classifies an emerging
trend as a major factor that has the potential to significantly impact
the market and contribute to its growth or decline.
This report is available at a USD 1,000 discount for a limited time
market snapshot before purchasing
In this report, Technavio highlights the enhancement of the POC and
biomarkers for malaria as one of the key emerging trends in the global
anti-malarial medicines market:
Global anti-malarial medicines market:
Enhancement of the POC and biomarkers for malaria
Diagnostics and biomarkers are being introduced to the world. Innovative
and better diagnostics are necessary for the potential control of malaria.
Biomarkers are useful for disease management as well as for formulating
strategies before the onset of the disease. Many studies are conducted
to formulate such strategies. As of now, the most proficient technique
for diagnosing malaria is the traditional blood smear analyzer.
“The Alere Malaria Ag P.f test introduced by Abbott is a rapid test
and is ten times more sensitive than the current malaria RDTs for
detection for the P.falciparum HRP-II antigen. This enables
significantly better identification of individuals with very low
parasitemia, with and without the evident symptoms of malaria
infection,” says a senior analyst at Technavio for research on
infectious and rare diseases.
Global anti-malarial medicines market:
This market research report segments the global anti-malarial medicines
market by product (artemisinin compounds, quinolines, and related
compounds, and other compounds) and geographical regions (APAC, EMEA,
and the Americas).
The EMEA led the market in 2017 with a market share of more than 48%,
followed by APAC and the Americas respectively. The region is expected
to continue to dominate the market during the forecast period.
Looking for more information on this market? Request
a free sample report
Technavio’s sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.
Some of the key topics covered in the report include:
- Market ecosystem
- Market characteristics
- Market segmentation analysis
- Market definition
- Market size and forecast
Five Forces Analysis
- Regional comparison
- Key leading countries
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Competitive scenario
is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio’s comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team
Media & Marketing Executive
+1 844 364 1100
UK: +44 203 893 3200